|
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy Clinical research trials and Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy. Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy clinical trial. Participants oftentimes recieve the most expert healthcare available for their Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy  Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
For Condition: Neutropenia
Status: No longer recruiting
Sponsor(s): Amgen ,
Synopsis: Physicians are conducting a clinical trial for patients with advanced breast cancer. Breast cancer can be treated with chemotherapy which can affect the bone marrow, where blood cells are produced. Neutrophils are a type of white blood cells that fight infection and are produced in the bone marrow. If the neutrophil count becomes low due to chemotherapy, a potentially serious condition called neutropenia occurs. Neutropenia is serious because it can affect the body's ability to protect against many types of infections. Pegfilgrastim is an investigational drug being evaluated for its potential ability to increase the number of neutrophils. The purpose of this study is to determine the safety and effectiveness of pegfilgrastim in preventing neutropenia following chemotherapy in patients with advanced breast cancer.
Details:
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Advanced breast cancer - 18 years of age or older - Patients who will be receiving Taxotere (docetaxel) chemotherapy
Total Enrollment: 928
Location and Contact Information:
Research Site
Columbia, Missouri,
United States
Research Site
Plantation, Florida,
United States
Research Site
Tamarac, Florida,
United States
Research Site
Bloomington, Indiana,
United States
Research Site
Long Beach, California,
United States
Research Site
Arlington, Virginia,
United States
Research Site
Brigham City, Utah,
United States
Research Site
Titusville, Florida,
United States
Research Site
Bakersfield, California,
United States
Research Site
Lakewood, Colorado,
United States
Research Site
Azusa, California,
United States
Research Site
Tarpon Springs, Florida,
United States
Research Site
Glendora, California,
United States
Research Site
Southfield, Michigan,
United States
Research Site
Albuquerque, New Mexico,
United States
Research Site
St. Joseph, Michigan,
United States
Research Site
Miami, Florida,
United States
Research Site
Norwich, Connecticut,
United States
Research Site
Poway, California,
United States
Research Site
Philadelphia, Pennsylvania,
United States
Research Site
Soquel, California,
United States
Research Site
Great Neck, New York,
United States
Research Site
Jefferson City, Missouri,
United States
Research Site
Richlands, Virginia,
United States
Research Site
Kissimmee, Florida,
United States
Research Site
Kalamazoo, Michigan,
United States
Research Site
Houston, Texas,
United States
Research Site
Valhalla, New York,
United States
Research Site
Norfolk, Virginia,
United States
Research Site
Ocala, Florida,
United States
Research Site
Logan, Utah,
United States
Research Site
Montgomery, Alabama,
United States
Research Site
Brooklyn, New York,
United States
Research Site
Lancaster, Pennsylvania,
United States
Research Site
Abingdon, Virginia,
United States
Research Site
Arlington Heights, Illinois,
United States
Research Site
St. Joseph, Missouri,
United States
Additional Information:
Study ID Numbers: 20010144;
Study Start Date: February 2002
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035594
Other Neutropenia Studies:
1. Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
2. Study of Unrelated Allogeneic Bone Marrow Transplantation in Patients With Benign Congenital Bone Marrow Failure Disorders
3. Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)
4. Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
5. Cancer in Inherited Bone Marrow Failure Syndromes
Related Studies:
Other Neutropenia Clinical Trials
Other California Clinical Trials
Other Long Beach Clinical Trials
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
|
|
|
|
|
|
|
|
